1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hua, Q.X.
Gozani, S.N.
Chance, R.E.
Hoffmann, J.A.
Frank, B.H.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
2
129
138
10.1038/nsb0295-129
7749917
Structure of a protein in a kinetic trap.
1995
UK
Nature
NATUAS
0006
0028-0836
354
238
Receptor Binding Redefined by a Structural Switch in a Mutant Human Insulin
1991
10.2210/pdb1xgl/pdb
pdb_00001xgl
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
DISULFIDE ISOMER WITH DISULFIDE BRIDGES AT A6-B7, A7-A11 AND A20-B19
2383.698
INSULIN
1
man
polymer
DISULFIDE ISOMER WITH DISULFIDE BRIDGES AT A6-B7, A7-A11 AND A20-B19
3433.953
INSULIN
1
man
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-04-01
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-10-10
REL
REL
DATE OF DATA-COLLECTION : 1993 IN 20% ACETIC ACID (ZINC-FREE)
10
1.9
298
K
BRUNGER
refinement
X-PLOR
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
ARG
22
0.299
SIDE CHAIN
2
B
ARG
22
0.262
SIDE CHAIN
4
B
ARG
22
0.301
SIDE CHAIN
5
B
ARG
22
0.299
SIDE CHAIN
6
B
ARG
22
0.263
SIDE CHAIN
7
B
ARG
22
0.296
SIDE CHAIN
8
B
ARG
22
0.287
SIDE CHAIN
9
B
ARG
22
0.287
SIDE CHAIN
10
B
ARG
22
0.231
SIDE CHAIN
2
7.13
1.10
114.20
121.33
A
A
A
CA
CB
SG
CYS
CYS
CYS
6
6
6
N
3
-3.12
0.50
120.30
117.18
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
3
-16.32
2.70
111.00
94.68
B
B
B
N
CA
C
TYR
TYR
TYR
26
26
26
N
6
7.08
1.10
114.20
121.28
A
A
A
CA
CB
SG
CYS
CYS
CYS
6
6
6
N
7
7.16
1.10
114.20
121.36
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
8
-3.94
0.60
121.00
117.06
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
9
-3.89
0.60
121.00
117.11
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
10
-28.51
1.60
110.90
82.39
A
A
A
CG1
CB
CG2
VAL
VAL
VAL
3
3
3
N
10
12.36
1.50
110.90
123.26
A
A
A
CA
CB
CG1
VAL
VAL
VAL
3
3
3
N
10
-27.68
1.60
110.90
83.22
B
B
B
CG1
CB
CG2
VAL
VAL
VAL
2
2
2
N
10
13.45
1.50
110.90
124.35
B
B
B
CA
CB
CG1
VAL
VAL
VAL
2
2
2
N
10
-28.47
1.60
110.90
82.43
B
B
B
CG1
CB
CG2
VAL
VAL
VAL
12
12
12
N
10
13.71
1.50
110.90
124.61
B
B
B
CA
CB
CG1
VAL
VAL
VAL
12
12
12
N
10
-27.44
1.60
110.90
83.46
B
B
B
CG1
CB
CG2
VAL
VAL
VAL
18
18
18
N
10
14.27
1.50
110.90
125.17
B
B
B
CA
CB
CG1
VAL
VAL
VAL
18
18
18
N
10
A
A
CB
CG1
VAL
VAL
3
3
0.206
0.021
1.524
1.730
N
10
B
B
CB
CG1
VAL
VAL
2
2
0.214
0.021
1.524
1.738
N
10
B
B
CB
CG1
VAL
VAL
12
12
0.220
0.021
1.524
1.744
N
10
B
B
CB
CG1
VAL
VAL
18
18
0.205
0.021
1.524
1.729
N
1
A
GLU
4
146.25
-56.98
1
A
GLN
5
40.59
-171.58
1
A
CYS
6
-10.97
-31.36
1
A
CYS
7
128.52
73.57
1
A
SER
9
-120.13
-70.56
1
A
CYS
11
5.89
73.42
1
B
GLN
4
-125.82
-166.60
1
B
HIS
5
-108.92
62.53
1
B
SER
9
-39.37
-39.72
1
B
TYR
26
116.99
65.88
1
B
PRO
28
-19.71
100.93
2
A
ILE
2
-108.01
-168.52
2
A
GLU
4
101.26
-38.99
2
A
CYS
6
15.73
72.66
2
A
THR
8
-19.72
-59.71
2
A
SER
9
-120.73
-72.51
2
A
CYS
11
20.15
79.51
2
B
GLN
4
-104.36
49.35
2
B
HIS
5
-16.33
79.22
2
B
GLU
21
-141.29
26.75
2
B
ARG
22
-22.01
152.77
2
B
TYR
26
-144.82
58.73
2
B
THR
27
-119.14
64.50
2
B
PRO
28
-35.10
150.87
2
B
LYS
29
-117.42
60.39
3
A
CYS
6
3.43
58.83
3
A
CYS
7
27.43
45.56
3
A
THR
8
-12.62
-61.89
3
A
SER
9
-146.90
-37.05
3
A
ILE
10
-147.63
59.33
3
B
ASN
3
-103.54
53.58
3
B
SER
9
-37.93
-36.29
3
B
PHE
24
-18.17
-52.93
3
B
PHE
25
-152.22
73.88
3
B
TYR
26
142.66
85.31
3
B
THR
27
-101.88
68.85
4
A
GLU
4
-5.52
67.49
4
A
GLN
5
-27.68
-25.21
4
A
CYS
7
-157.60
53.38
4
A
THR
8
-15.02
-79.66
4
A
SER
9
-132.41
-69.11
4
A
CYS
11
-6.34
74.37
4
B
GLN
4
-83.65
40.78
4
B
HIS
5
-105.78
62.62
4
B
CYS
7
134.19
90.27
4
B
SER
9
-23.60
-34.99
4
B
GLU
21
-159.02
41.29
4
B
THR
27
-112.96
71.49
4
B
PRO
28
-57.58
88.32
4
B
LYS
29
-117.42
50.35
5
A
GLU
4
146.20
-56.96
5
A
GLN
5
40.70
-171.62
5
A
CYS
6
-10.98
-31.27
5
A
CYS
7
128.42
73.59
5
A
SER
9
-120.06
-70.59
5
A
CYS
11
6.05
73.41
5
B
GLN
4
-125.78
-166.59
5
B
HIS
5
-108.92
62.56
5
B
SER
9
-39.35
-39.78
5
B
TYR
26
117.08
65.90
5
B
PRO
28
-19.71
100.95
6
A
ILE
2
-108.08
-168.58
6
A
GLU
4
101.22
-38.97
6
A
CYS
6
15.75
72.67
6
A
THR
8
-19.69
-59.72
6
A
SER
9
-120.75
-72.52
6
A
CYS
11
20.12
79.53
6
B
GLN
4
-104.35
49.28
6
B
HIS
5
-16.36
79.23
6
B
GLU
21
-141.27
26.73
6
B
ARG
22
-21.94
152.82
6
B
TYR
26
-144.84
58.67
6
B
THR
27
-119.06
64.43
6
B
PRO
28
-35.13
150.86
6
B
LYS
29
-117.32
60.30
7
A
GLU
4
-0.98
93.43
7
A
GLN
5
-151.85
48.53
7
A
CYS
6
2.49
94.64
7
A
CYS
7
33.42
39.62
7
A
THR
8
-7.37
-67.35
7
A
SER
9
-125.91
-66.34
7
A
CYS
11
8.93
65.84
7
A
TYR
19
-90.64
30.12
7
B
ASN
3
72.85
42.42
7
B
HIS
5
-110.44
69.12
7
B
CYS
7
-93.86
-60.07
7
B
SER
9
-39.09
-33.65
7
B
VAL
18
-98.44
-72.98
7
B
CYS
19
-149.53
-50.67
7
B
GLU
21
116.49
49.43
7
B
ARG
22
12.28
86.22
7
B
PHE
24
-1.16
91.08
7
B
TYR
26
-121.36
-57.30
7
B
THR
27
-161.01
44.99
8
A
ILE
2
58.76
-166.34
8
A
VAL
3
45.45
-165.36
8
A
GLN
5
135.58
167.34
8
A
THR
8
-6.43
-53.74
8
A
SER
9
-142.13
-63.21
8
A
CYS
11
26.59
63.48
8
B
GLN
4
-120.30
-169.85
8
B
HIS
5
-107.82
68.93
8
B
CYS
7
-105.72
41.40
8
B
GLU
21
-109.87
42.13
8
B
TYR
26
-106.22
-68.14
8
B
THR
27
-170.84
49.01
8
B
LYS
29
-0.48
98.44
9
A
ILE
2
58.83
-166.36
9
A
VAL
3
45.45
-165.36
9
A
GLN
5
135.54
167.34
9
A
THR
8
-6.38
-53.76
9
A
SER
9
-142.18
-63.15
9
A
CYS
11
26.58
63.48
9
B
GLN
4
-120.27
-169.82
9
B
HIS
5
-107.88
69.01
9
B
CYS
7
-105.70
41.43
9
B
GLU
21
-109.84
42.11
9
B
TYR
26
-106.24
-68.13
9
B
THR
27
-170.88
49.05
9
B
LYS
29
-0.41
98.36
10
A
VAL
3
-69.08
-160.18
10
A
GLU
4
109.23
-28.14
10
A
GLN
5
-90.77
33.12
10
A
CYS
6
84.92
48.93
10
A
CYS
7
69.48
63.39
10
A
SER
9
-131.18
-74.48
10
A
CYS
11
41.31
76.01
10
B
ASN
3
-64.66
99.82
10
B
HIS
5
-18.65
72.60
10
B
GLU
21
-142.80
41.95
10
B
TYR
26
-160.73
64.84
10
B
PRO
28
-20.06
112.85
10
B
LYS
29
-147.41
43.75
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
1
N
N
2
N
N
A
LEU
13
A
LEU
13
HELX_P
A
TYR
19
A
TYR
19
5
H1
7
B
SER
9
B
SER
9
HELX_P
B
VAL
18
B
VAL
18
5
H2
10
disulf
2.023
A
CYS
6
A
SG
CYS
6
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.015
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.015
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE
HORMONE, GLUCOSE METABOLISM
INS_HUMAN
UNP
1
1
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKAGIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
1
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKTGIVEQCCTGVCSLYQLENYCN
31
51
1XGL
1
21
P01308
A
1
1
21
1
30
1XGL
1
30
P01308
B
2
1
30
1
P 1